COMP and rheumatoid arthritis: We hypothesize that the sub-population of patients who achieved remission at 6 months but still showed increased COMP expression may have a higher risk of relapse compared to patients with stable levels of COMP, which is consistent with our finding that the COMP+ fibroblast population co-expresses genes previously reported to be enriched in RA patients refractory to multiple lines of therapy17.